IL-33/ST2 axis in autoimmune disease
Abstract
No abstract availableKeywords
Funding Information
- Mashhad University of Medical Sciences
This publication has 136 references indexed in Scilit:
- The Role of IL-33 in Gut Mucosal InflammationMediators of Inflammation, 2013
- Deletion of IL-33R (ST2) Abrogates Resistance to EAE in BALB/C Mice by Enhancing Polarization of APC to Inflammatory PhenotypePLOS ONE, 2012
- IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin GProceedings of the National Academy of Sciences, 2012
- Novel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammationTherapeutic Advances in Gastroenterology, 2011
- Role of IL-33 in inflammation and diseaseJournal of Inflammation, 2011
- IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cellsJournal of Experimental Medicine, 2010
- IL-33 augments substance P–induced VEGF secretion from human mast cells and is increased in psoriatic skinProceedings of the National Academy of Sciences, 2010
- IL-33–activated dendritic cells induce an atypical TH2-type responseJournal of Allergy and Clinical Immunology, 2009
- IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivoProceedings of the National Academy of Sciences, 2007
- Cytokines and autoimmunityNature Reviews Immunology, 2002